GW Henssler & Associates’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
Other funds holding HOLX
GW Henssler & Associates's HOLX Position: Q2 2022 in Review
GW Henssler & Associates sold out of Hologic (HOLX) in Q2 2022, closing a stake of 7,058 shares — an estimated $542K sold.
GW Henssler & Associates first reported a position in HOLX in Q2 2021 and held it in 3 quarters. The position peaked at $542K in Q1 2022. 695 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.
- GW Henssler & Associates reported no remaining Hologic position as of Q2 2022 after selling out during the quarter.
- GW Henssler & Associates sold 7,058 Hologic shares in Q2 2022, an estimated $542K.
- GW Henssler & Associates first reported a position in Hologic in Q2 2021 and held it in 3 quarters.
- GW Henssler & Associates's Hologic position peaked at $542K in Q1 2022.
- 695 funds tracked by Wall St. Rank held Hologic as of Q2 2022.
Based on GW Henssler & Associates's 13F filing for Q2 2022, filed 4 Aug 2022.